REPORT ID 4495

United States Peanut Allergy Therapeutics Market Report 2017

Publish Date
18-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the United States Peanut Allergy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Peanut Allergy Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Peanut Allergy Therapeutics market competition by top manufacturers/players, with Peanut Allergy Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Adverum Biotechnologies Inc
    Aimmune Therapeutics Inc
    Alfacyte Ltd
    Allergy Therapeutics Plc
    AnaptysBio Inc
    ASIT Biotech SA
    Astellas Pharma Inc
    BioLingus AG
    DBV Technologies SA
    HAL Allergy BV
    Intrommune Therapeutics
    Sanofi
    Selecta Biosciences Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ANB-020
    ANN-004
    AR-101
    ASP-0892
    DBV-712
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Peanut Allergy Therapeutics Market Report 2017
1 Peanut Allergy Therapeutics Overview
    1.1 Product Overview and Scope of Peanut Allergy Therapeutics
    1.2 Classification of Peanut Allergy Therapeutics by Product Category
        1.2.1 United States Peanut Allergy Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Peanut Allergy Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 ANB-020
        1.2.4 ANN-004
        1.2.5 AR-101
        1.2.6 ASP-0892
        1.2.7 DBV-712
        1.2.8 Others
    1.3 United States Peanut Allergy Therapeutics Market by Application/End Users
        1.3.1 United States Peanut Allergy Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Home Care
    1.4 United States Peanut Allergy Therapeutics Market by Region
        1.4.1 United States Peanut Allergy Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Peanut Allergy Therapeutics Status and Prospect (2012-2022)
        1.4.3 Southwest Peanut Allergy Therapeutics Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Peanut Allergy Therapeutics Status and Prospect (2012-2022)
        1.4.5 New England Peanut Allergy Therapeutics Status and Prospect (2012-2022)
        1.4.6 The South Peanut Allergy Therapeutics Status and Prospect (2012-2022)
        1.4.7 The Midwest Peanut Allergy Therapeutics Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Peanut Allergy Therapeutics (2012-2022)
        1.5.1 United States Peanut Allergy Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 United States Peanut Allergy Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Peanut Allergy Therapeutics Market Competition by Players/Suppliers
    2.1 United States Peanut Allergy Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Peanut Allergy Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Peanut Allergy Therapeutics Average Price by Players/Suppliers (2012-2017)
    2.4 United States Peanut Allergy Therapeutics Market Competitive Situation and Trends
        2.4.1 United States Peanut Allergy Therapeutics Market Concentration Rate
        2.4.2 United States Peanut Allergy Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Peanut Allergy Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Peanut Allergy Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Peanut Allergy Therapeutics Sales and Market Share by Region (2012-2017)
    3.2 United States Peanut Allergy Therapeutics Revenue and Market Share by Region (2012-2017)
    3.3 United States Peanut Allergy Therapeutics Price by Region (2012-2017)

4 United States Peanut Allergy Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Peanut Allergy Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Peanut Allergy Therapeutics Revenue and Market Share by Type (2012-2017)
    4.3 United States Peanut Allergy Therapeutics Price by Type (2012-2017)
    4.4 United States Peanut Allergy Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Peanut Allergy Therapeutics Sales (Volume) by Application (2012-2017)
    5.1 United States Peanut Allergy Therapeutics Sales and Market Share by Application (2012-2017)
    5.2 United States Peanut Allergy Therapeutics Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Peanut Allergy Therapeutics Players/Suppliers Profiles and Sales Data
    6.1 Adverum Biotechnologies Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Adverum Biotechnologies Inc Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Aimmune Therapeutics Inc
        6.2.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Aimmune Therapeutics Inc Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Alfacyte Ltd
        6.3.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Alfacyte Ltd Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Allergy Therapeutics Plc
        6.4.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Allergy Therapeutics Plc Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AnaptysBio Inc
        6.5.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AnaptysBio Inc Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 ASIT Biotech SA
        6.6.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 ASIT Biotech SA Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Astellas Pharma Inc
        6.7.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Astellas Pharma Inc Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 BioLingus AG
        6.8.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 BioLingus AG Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 DBV Technologies SA
        6.9.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 DBV Technologies SA Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 HAL Allergy BV
        6.10.2 Peanut Allergy Therapeutics Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 HAL Allergy BV Peanut Allergy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Intrommune Therapeutics
    6.12 Sanofi
    6.13 Selecta Biosciences Inc

7 Peanut Allergy Therapeutics Manufacturing Cost Analysis
    7.1 Peanut Allergy Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Peanut Allergy Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Peanut Allergy Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Peanut Allergy Therapeutics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Peanut Allergy Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Peanut Allergy Therapeutics Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Peanut Allergy Therapeutics Sales Volume Forecast by Type (2017-2022)
    11.3 United States Peanut Allergy Therapeutics Sales Volume Forecast by Application (2017-2022)
    11.4 United States Peanut Allergy Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer